Literature DB >> 33177028

[Predictive factors of left ventricular reverse remodeling in patients with idiopathic or secondary dilated cardiomyopathy].

Han Cai1, Zhoufei Fang2, Zhiyuan Weng1, Xueqing Jin2.   

Abstract

OBJECTIVE: To investigate the occurrence of left ventricular reverse remodeling (LVRR) and its predictive factors in patients with idiopathic or secondary dilated cardiomyopathy (DCM).
METHODS: A cross-sectional survey was conducted in a consecutive cohort of patients with DCM admitted in our department between January, 2012 and June, 2016. Based on dynamic echocardiographic findings, LVRR was defined as an absolute increase in left ventricular ejection fraction (LVEF) by ≥100% or an absolute value of LVEF ≥45% with simultaneously an absolute decrease in end-diastolic diameter (LVEDD) ≥10 mm or an absolute value of LVEDD ≤55 mm (in men) or ≤50 mm (in women). The patients with LVRR and those without LVRR were compared for clinical data at admission to identify the potential factors for predicting LVRR.
RESULTS: A total of 462 patients, who were followed up for 24.13±15.60 months, were included in this survey. In patients with idiopathic DCM who had LVRR, LVEDD was reduced (P < 0.01), LVEF was improved (P < 0.01) and the mean exercise tolerance was increased significantly (P < 0.01) compared with those in patients without LVRR. Multiple logistic regression analysis showed that a shorter course of heart failure (OR=0.913, P < 0.01), a high systolic blood pressure (OR=1.062, P < 0.01), absence of electrolyte imbalance (OR=0.347, P < 0.01), a low red cell distribution width (OR=0.205, P < 0.01), a smaller LVEDD (OR=0.799, P < 0.01) and a greater LVEF (OR= 1.142, P < 0.01) were independent predictors of LVRR in the idiopathic patients. In patients with secondary DCM, LVEDD was reduced (P < 0.01), LVEF was improved (P < 0.01), and the mean exercise tolerance was increased significantly (P < 0.01) compared with those in patients without LVRR. Multiple logistic regression analysis showed that a shorter course of heart failure (OR= 0.954, P < 0.01), a low red cell distribution width (OR=1.011, P < 0.01), and implementation of etiological treatment (OR=1.073, P < 0.01) were independent predictors of LVRR in patients with secondary DCM.
CONCLUSIONS: The exercise tolerance, cardiac structure and function can be reversed in some of the patients with idiopathic or secondary DCM by administration of standard therapy for heart failure and etiological treatment.

Entities:  

Keywords:  dilated cardiomyopathy; left ventricular reverse remodeling; predictors

Year:  2018        PMID: 33177028      PMCID: PMC6765619          DOI: 10.3969/j.issn.1673-4254.2018.01.13

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  24 in total

Review 1.  Myocardial reverse remodeling.

Authors:  Jennifer L Hellawell; Kenneth B Margulies
Journal:  Cardiovasc Ther       Date:  2010-11-25       Impact factor: 3.023

2.  Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study.

Authors:  Dennis M McNamara; Randall C Starling; Leslie T Cooper; John P Boehmer; Paul J Mather; Karen M Janosko; John Gorcsan; Kevin E Kip; G William Dec
Journal:  J Am Coll Cardiol       Date:  2011-09-06       Impact factor: 24.094

Review 3.  Red blood cell distribution width: A simple parameter with multiple clinical applications.

Authors:  Gian Luca Salvagno; Fabian Sanchis-Gomar; Alessandra Picanza; Giuseppe Lippi
Journal:  Crit Rev Clin Lab Sci       Date:  2014-12-23       Impact factor: 6.250

4.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Kardiol Pol       Date:  2016       Impact factor: 3.108

5.  Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy.

Authors:  Jin-Oh Choi; Eun Young Kim; Ga Yeon Lee; Sang-Chol Lee; Seung Woo Park; Duk-Kyung Kim; Jae K Oh; Eun-Seok Jeon
Journal:  Circ J       Date:  2012-10-24       Impact factor: 2.993

6.  Effect of High-Intensity Interval Versus Continuous Exercise Training on Functional Capacity and Quality of Life in Patients With Coronary Artery Disease: A RANDOMIZED CLINICAL TRIAL.

Authors:  Koldobika Villelabeitia Jaureguizar; Davinia Vicente-Campos; Lorena Ruiz Bautista; Cesar Hernández de la Peña; María José Arriaza Gómez; María José Calero Rueda; Ignacio Fernández Mahillo
Journal:  J Cardiopulm Rehabil Prev       Date:  2016 Mar-Apr       Impact factor: 2.081

7.  Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction.

Authors:  Payman Zamani; Deepa Rawat; Prithvi Shiva-Kumar; Salvatore Geraci; Rushik Bhuva; Prasad Konda; Paschalis-Thomas Doulias; Harry Ischiropoulos; Raymond R Townsend; Kenneth B Margulies; Thomas P Cappola; David C Poole; Julio A Chirinos
Journal:  Circulation       Date:  2014-12-22       Impact factor: 29.690

8.  Myocardial alterations and clinical implications associated with recovery of cardiac function in dilated cardiomyopathy with obesity.

Authors:  Tsunenori Saito; Kuniya Asai; Shigeru Sato; Gen Takagi; Hitoshi Takano; Hiroshi Takahashi; Masahiro Yasutake; Kyoichi Mizuno
Journal:  Int J Cardiol       Date:  2012-10-15       Impact factor: 4.164

9.  Effects of trimetazidine on submaximal exercise test in patients with acute myocardial infarction.

Authors:  Niyazi Güler; Beyhan Eryonucu; Ahmet Günes; Unal Güntekin; Mustafa Tuncer; Hanefi Ozbek
Journal:  Cardiovasc Drugs Ther       Date:  2003-07       Impact factor: 3.727

10.  The value of a complete blood count in predicting cancer of the colon.

Authors:  Derrick W Spell; Dennie V Jones; William F Harper; J David Bessman
Journal:  Cancer Detect Prev       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.